To further understand the impact of differential transcriptional regulation of RASSF2 in AML, we performed gene expression profiling in a non-t(8;21) AML cell context following shRNA-mediated depletion of RASSF2 transcript (Fig. 2a). The gene discussed is RASSF2; the disease is acute myeloid leukemia.